Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
DSMM XVII
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
- NCT03948035 ↗
- Active, not recruiting
- Wuerzburg University Hospital
- Focused
We haven't built an HCP commentary report on DSMM XVII yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on DSMM XVII so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd Prior to and Following Auto-SCT in Newly Diagnosed Multipe Myeloma and Subsequent Maintenance With Elotuzumab and Lenalidomide Versus Single-Agent Lenalidomide- A Phase III Study by DSMM
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Newly Diagnosed Multiple Myeloma
- Interventions
- Elotuzumab; Carfilzomib; Lenalidomide; Dexamethasone; autologous stem cell transplant
- Arms
- E-KRd/ Arm A · Experimental
- KRd/ Arm B · Active comparator
- Enrollment
- 576 (estimated)
- Primary outcomes
- Induction phase
- Maintenance phase
- Sponsor
- Wuerzburg University Hospital with ClinAssess GmbH, Arbeitsgemeinschaft medikamentoese Tumortherapie
- Start
- Aug 28, 2018
- Primary completion
- Aug 2029 (estimated)
- Results posted
- No
- Registry record
- NCT03948035 · updated May 6, 2023
Publications
linked from the registry- Rassner M, Baur R, Wasch R, Schiffer M, Schneider J, Mackensen A, Engelhardt M. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma. BMC Nephrol. 2021 Jan 18;22(1):32. doi: 10.1186/s12882-020-02226-5. PubMed 33461512